Tongqiao Mingmu decoction

Tongqiao Mingmu decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Eye Hospital of China Academy of Chinese Medical Sciences. It is primarily investigated for the treatment of retinal artery occlusion (RAO), specifically for patients who present more than 12 hours after the onset of symptoms. The decoction is typically administered as part of a comprehensive clinical regimen that may include anterior chamber puncture, cobamamide, and other intravenous TCM preparations. In the context of TCM theory, 'Tongqiao' refers to opening the orifices to restore sensory function and circulation, while 'Mingmu' refers to the improvement of visual acuity. The formulation is designed to promote blood circulation, resolve blood stasis, and provide neuroprotective support to the ischemic retina.

Other names

Tongqiao Mingmu TangTongqiao Mingmu traditional Chinese medicine regimen